Title: Functional characterization of three mouse formyl peptide receptors.
Journal: Molecular pharmacology 20130201
Title: Airway activation of formyl peptide receptors inhibits Th1 and Th17 cell responses via inhibition of mediator release from immune and inflammatory cells and maturation of dendritic cells.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20120215
Title: A WKYMVm-containing combination elicits potent anti-tumor activity in heterotopic cancer animal model.
Journal: PloS one 20120101
Title: Stimulation of human formyl peptide receptors by calpain inhibitors: homology modeling of receptors and ligand docking simulation.
Journal: Archives of biochemistry and biophysics 20111215
Title: NADPH-oxidase-dependent reactive oxygen species mediate EGFR transactivation by FPRL1 in WKYMVm-stimulated human lung cancer cells.
Journal: Free radical biology & medicine 20110915
Title: Role(s) of formyl-peptide receptors expressed in nasal epithelial cells.
Journal: Journal of biological regulators and homeostatic agents 20110101
Title: Kinetic and thermodynamic analyses of adhesion of a peptide, Trp-Lys-Tyr-Met-Val-D-Met (WKYMVm), and human formyl peptide receptor (hFPR).
Journal: Biotechnology letters 20100601
Title: PKC-delta controls the fMLF-induced overproduction of superoxide by neutrophils.
Journal: Free radical biology & medicine 20100115
Title: Functional expression of formyl peptide receptor family in human NK cells.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20091101
Title: Lipoxin A(4) metabolites/analogues from two commercial sources have no effects on TNF-alpha-mediated priming or activation through the neutrophil formyl peptide receptors.
Journal: Scandinavian journal of immunology 20091001
Title: 6-methyl-2,4-disubstituted pyridazin-3(2H)-ones: a novel class of small-molecule agonists for formyl peptide receptors.
Journal: Journal of medicinal chemistry 20090827
Title: Oxygen radical production in leukocytes and disease severity in multiple sclerosis.
Journal: Journal of neuroimmunology 20090818
Title: JAM-A promotes neutrophil chemotaxis by controlling integrin internalization and recycling.
Journal: Journal of cell science 20090115
Title: Cyclosporin H, Boc-MLF and Boc-FLFLF are antagonists that preferentially inhibit activity triggered through the formyl peptide receptor.
Journal: Inflammation 20071201
Title: Oxygen radical production and severity of the Guillain--Barré syndrome.
Journal: Journal of neuroimmunology 20071201
Title: Formyl peptide receptor like 1 differentially requires mitogen-activated protein kinases for the induction of glial fibrillary acidic protein and interleukin-1alpha in human U87 astrocytoma cells.
Journal: Cellular signalling 20071001
Title: Pharmacological characterization of a novel nonpeptide antagonist for formyl peptide receptor-like 1.
Journal: Molecular pharmacology 20071001
Title: The non-steroidal anti-inflammatory drug piroxicam blocks ligand binding to the formyl peptide receptor but not the formyl peptide receptor like 1.
Journal: Biochemical pharmacology 20071001
Title: Discovery of Trp-Nle-Tyr-Met as a novel agonist for human formyl peptide receptor-like 1.
Journal: Biochemical pharmacology 20070715
Title: Protein kinase C-alpha and -delta are required for NADPH oxidase activation in WKYMVm-stimulated IMR90 human fibroblasts.
Journal: Archives of biochemistry and biophysics 20070315
Title: Differential production of leukotriene B4 or prostaglandin E2 by WKYMVm or serum amyloid A via formyl peptide receptor-like 1.
Journal: Biochemical pharmacology 20060928
Title: The peptide Trp-Lys-Tyr-Met-Val-D-Met activates neutrophils through the formyl peptide receptor only when signaling through the formylpeptide receptor like 1 is blocked. A receptor switch with implications for signal transduction studies with inhibitors and receptor antagonists.
Journal: Biochemical pharmacology 20060514
Title: Changes in activation states of murine polymorphonuclear leukocytes (PMN) during inflammation: a comparison of bone marrow and peritoneal exudate PMN.
Journal: Clinical and vaccine immunology : CVI 20060501
Title: Granulocyte function is stimulated by a novel hexapeptide, WKYMVm, in chemotherapy-treated cancer patients.
Journal: Experimental hematology 20060401
Title: The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met as a novel adjuvant for DNA vaccine.
Journal: Vaccine 20050907
Title: The immunostimulatory peptide WKYMVm-NH activates bone marrow mouse neutrophils via multiple signal transduction pathways.
Journal: Scandinavian journal of immunology 20050801
Title: The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met inhibits human monocyte-derived dendritic cell maturation via formyl peptide receptor and formyl peptide receptor-like 2.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20050715
Title: The synthetic chemoattractant peptide WKYMVm induces superoxide production by human eosinophils via the phosphoinositide 3-kinase-mediated activation of ERK1/2.
Journal: International archives of allergy and immunology 20050101
Title: Lysophosphatidic acid is a mediator of Trp-Lys-Tyr-Met-Val-d-Met-induced calcium influx.
Journal: Biochemical and biophysical research communications 20041105
Title: A novel nonpeptide ligand for formyl peptide receptor-like 1.
Journal: Molecular pharmacology 20041101
Title: Activation of formyl peptide receptor-like 1 by WKYMVm induces serine phosphorylation of STAT3, which inhibits its tyrosine phosphorylation and nuclear translocation induced by hydrogen peroxide.
Journal: Life sciences 20040917
Title: Agonist-induced trafficking of the low-affinity formyl peptide receptor FPRL1.
Journal: Cellular and molecular life sciences : CMLS 20040701
Title: The mechanism for activation of the neutrophil NADPH-oxidase by the peptides formyl-Met-Leu-Phe and Trp-Lys-Tyr-Met-Val-Met differs from that for interleukin-8.
Journal: Immunology 20040601
Title: Trp-Lys-Tyr-Met-Val-Met stimulates phagocytosis via phospho-lipase D-dependent signaling in mouse dendritic cells.
Journal: Experimental & molecular medicine 20040430
Title: Low-affinity receptor-mediated induction of superoxide by N-formyl-methionyl-leucyl-phenylalanine and WKYMVm in IMR90 human fibroblasts.
Journal: Free radical biology & medicine 20040115
Title: Differential activation of formyl peptide receptor-like 1 by peptide ligands.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20031215
Title: Membrane lipid microdomains differentially regulate intracellular signaling events in human neutrophils.
Journal: International immunopharmacology 20031201
Title: Differential activation of formyl peptide receptor signaling by peptide ligands.
Journal: Molecular pharmacology 20031001
Title: Differential signaling of formyl peptide receptor-like 1 by Trp-Lys-Tyr-Met-Val-Met-CONH2 or lipoxin A4 in human neutrophils.
Journal: Molecular pharmacology 20030901
Title: Histamine inhibits neutrophil NADPH oxidase activity triggered by the lipoxin A4 receptor-specific peptide agonist Trp-Lys-Tyr-Met-Val-Met.
Journal: Scandinavian journal of immunology 20030901
Title: NADPH-oxidase activation in murine neutrophils via formyl peptide receptors.
Journal: Experimental cell research 20030115
Title: Phagocyte activation by Trp-Lys-Tyr-Met-Val-Met, acting through FPRL1/LXA4R, is not affected by lipoxin A4.
Journal: Scandinavian journal of immunology 20021101
Title: The chemoattractant Trp-Lys-Tyr-Met-Val-D-Met activates eosinophils through the formyl peptide receptor and one of its homologues, formyl peptide receptor-like 1.
Journal: Journal of leukocyte biology 20021001
Title: Human dendritic cells express functional formyl peptide receptor-like-2 (FPRL2) throughout maturation.
Journal: Journal of leukocyte biology 20020901
Title: The synthetic chemoattractant peptide, Trp-Lys-Tyr-Met-Val-D-Met, enhances monocyte survival via PKC-dependent Akt activation.
Journal: Journal of leukocyte biology 20020201
Title: Beta amyloid peptide (Abeta42) is internalized via the G-protein-coupled receptor FPRL1 and forms fibrillar aggregates in macrophages.
Journal: FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20011101
Title: The synthetic peptide Trp-Lys-Tyr-Met-Val-Met-NH2 specifically activates neutrophils through FPRL1/lipoxin A4 receptors and is an agonist for the orphan monocyte-expressed chemoattractant receptor FPRL2.
Journal: The Journal of biological chemistry 20010615
Title: The synthetic peptide WKYMVm attenuates the function of the chemokine receptors CCR5 and CXCR4 through activation of formyl peptide receptor-like 1.
Journal: Blood 20010515
Title: The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met is a potent chemotactic agonist for mouse formyl peptide receptor.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20001015
Title: The synthetic chemoattractant Trp-Lys-Tyr-Met-Val-DMet activates neutrophils preferentially through the lipoxin A(4) receptor.
Journal: Blood 20000301
Title: Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation.
Journal: Journal of immunology (Baltimore, Md. : 1950) 19991215
Title: Trp-Lys-Tyr-Met-Val-D-Met is a chemoattractant for human phagocytic cells.
Journal: Journal of leukocyte biology 19991201
Title: Trp-Lys-Tyr-Met-Val-D-Met stimulates superoxide generation and killing of Staphylococcus aureus via phospholipase D activation in human monocytes.
Journal: Journal of leukocyte biology 19990201
Title: Trp-Lys-Tyr-Met-Val-Met activates mitogen-activated protein kinase via a PI-3 kinase-mediated pathway independent of PKC.
Journal: Life sciences 19990101
Title: Christophe T, et al. The synthetic peptide Trp-Lys-Tyr-Met-Val-Met-NH2 specifically activates neutrophils through FPRL1/lipoxin A4 receptors and is an agonist for the orphan monocyte-expressed chemoattractant receptor FPRL2. J Biol Chem. 2001 Jun 15;276(24):21585-93.
Title: Christophe T, et al. Phagocyte activation by Trp-Lys-Tyr-Met-Val-Met, acting through FPRL1/LXA4R, is not affected by lipoxin A4. Scand J Immunol. 2002 Nov;56(5):470-6.
